Literature DB >> 27988840

Claudin proteins, outside-in signaling, and carcinogenesis.

Amar B Singh1,2,3, Srijayaprakash B Uppada2, Punita Dhawan4,5,6.   

Abstract

Environment affects an individual's development and disease risk which then suggest that the environmental cues must have ways of reaching to the cellular nuclei to orchestrate desired genetic changes. Polarized and differentiated epithelial cells join together by cell-cell adhesions to create a protective sheet which separates body's internal milieu from its environment, albeit in highly regulated manner. Among these cell-cell adhesions, a key role of tight junction, the apical cell-cell adhesion, in maintaining epithelial cell polarity and differentiation is well recognized. Moreover, significant changes in expression and cellular distribution of claudin proteins, integral component of the tight junction, characterize pathophysiological changes including neoplastic growth and progression. Studies have further confirmed existence of complex claudin-based interactomes and demonstrated that changes in such protein partnering can influence barrier integrity and communication between a cell and its environment to produce undesired outcome. Cell signaling is the process by which cells respond to their environment to make dynamic decisions to live, grow and proliferate, or die. Thus, pivotal role of the deregulated tight junction structure/function in influencing cellular signaling cascades to alter cellular phenotype can be envisaged, however, is not well understood. Needless to mention that advanced knowledge in this area can help improve therapeutic considerations and preventive measures. Here, we discuss potential role of the tight junction in the regulation of "outside-in" signaling to regulate cancer growth, with specific focus upon the claudin family of proteins.

Entities:  

Keywords:  Cancer progression; Claudin; Signaling; Stem cell; Tight junction

Mesh:

Substances:

Year:  2016        PMID: 27988840      PMCID: PMC6166644          DOI: 10.1007/s00424-016-1919-1

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  75 in total

1.  Inflammation and disruption of the mucosal architecture in claudin-7-deficient mice.

Authors:  Lei Ding; Zhe Lu; Oded Foreman; Rodney Tatum; Qun Lu; Randall Renegar; Jian Cao; Yan-Hua Chen
Journal:  Gastroenterology       Date:  2011-10-29       Impact factor: 22.682

2.  Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast.

Authors:  Scott L Kominsky; Pedram Argani; Dorian Korz; Ella Evron; Venu Raman; Elizabeth Garrett; Alan Rein; Guido Sauter; Olli-P Kallioniemi; Saraswati Sukumar
Journal:  Oncogene       Date:  2003-04-03       Impact factor: 9.867

3.  Claudin-1 promotes TNF-α-induced epithelial-mesenchymal transition and migration in colorectal adenocarcinoma cells.

Authors:  Ajaz A Bhat; Rizwan Ahmad; SrijayaPrakash B Uppada; Amar B Singh; Punita Dhawan
Journal:  Exp Cell Res       Date:  2016-10-11       Impact factor: 3.905

4.  The PDZ domains of zonula occludens-1 induce an epithelial to mesenchymal transition of Madin-Darby canine kidney I cells. Evidence for a role of beta-catenin/Tcf/Lef signaling.

Authors:  M Reichert; T Müller; W Hunziker
Journal:  J Biol Chem       Date:  2000-03-31       Impact factor: 5.157

5.  Loss of claudins-1 and -7 and expression of claudins-3 and -4 correlate with prognostic variables in prostatic adenocarcinomas.

Authors:  Gregory M Sheehan; Bhaskar V S Kallakury; Christine E Sheehan; Hugh A G Fisher; Ronald P Kaufman; Jeffrey S Ross
Journal:  Hum Pathol       Date:  2007-02-15       Impact factor: 3.466

Review 6.  The role of uvomorulin in the formation of epithelial occluding junctions.

Authors:  B Gumbiner; K Simons
Journal:  Ciba Found Symp       Date:  1987

Review 7.  Cancer stem cell genomics: the quest for early markers of malignant progression.

Authors:  Oswaldo Keith Okamoto
Journal:  Expert Rev Mol Diagn       Date:  2009-09       Impact factor: 5.225

8.  Claudin-2 expression increases tumorigenicity of colon cancer cells: role of epidermal growth factor receptor activation.

Authors:  P Dhawan; R Ahmad; R Chaturvedi; J J Smith; R Midha; M K Mittal; M Krishnan; X Chen; S Eschrich; T J Yeatman; R C Harris; M K Washington; K T Wilson; R D Beauchamp; A B Singh
Journal:  Oncogene       Date:  2011-03-07       Impact factor: 9.867

9.  Claudin-4 expression in gastric cancer cells enhances the invasion and is associated with the increased level of matrix metalloproteinase-2 and -9 expression.

Authors:  Tsann-Long Hwang; Tzu-Tsung Changchien; Chee-Chan Wang; Chi-Ming Wu
Journal:  Oncol Lett       Date:  2014-06-27       Impact factor: 2.967

10.  Claudin-4 controls the receptor tyrosine kinase EphA2 pro-oncogenic switch through β-catenin.

Authors:  Xiying Shang; Xinjian Lin; Stephen B Howell
Journal:  Cell Commun Signal       Date:  2014-10-25       Impact factor: 5.712

View more
  17 in total

1.  Claudin-2 suppresses GEF-H1, RHOA, and MRTF, thereby impacting proliferation and profibrotic phenotype of tubular cells.

Authors:  Qinghong Dan; Yixuan Shi; Razieh Rabani; Shruthi Venugopal; Jenny Xiao; Shaista Anwer; Mei Ding; Pam Speight; Wanling Pan; R Todd Alexander; András Kapus; Katalin Szászi
Journal:  J Biol Chem       Date:  2019-09-03       Impact factor: 5.157

2.  Anti-Claudin-1 Conjugated to a Near-Infrared Fluorophore Targets Colon Cancer in PDOX Mouse Models.

Authors:  Hannah M Hollandsworth; Thinzar M Lwin; Siamak Amirfakhri; Filemoni Filemoni; Surinder K Batra; Robert M Hoffman; Punita Dhawan; Michael Bouvet
Journal:  J Surg Res       Date:  2019-05-09       Impact factor: 2.192

Review 3.  A review of tumor-specific fluorescence-guided surgery for colorectal cancer.

Authors:  Hannah M Hollandsworth; Michael A Turner; Robert M Hoffman; Michael Bouvet
Journal:  Surg Oncol       Date:  2020-11-29       Impact factor: 3.279

4.  The axis IL-10/claudin-10 is implicated in the modulation of aggressiveness of melanoma cells by B-1 lymphocytes.

Authors:  Elizabeth Cristina Perez; Patricia Xander; Maria Fernanda Lucatelli Laurindo; Ronni Rômulo Novaes E Brito; Bruno Camolese Vivanco; Renato Arruda Mortara; Mario Mariano; José Daniel Lopes; Alexandre Castro Keller
Journal:  PLoS One       Date:  2017-11-16       Impact factor: 3.240

5.  Obesity-induces Organ and Tissue Specific Tight Junction Restructuring and Barrier Deregulation by Claudin Switching.

Authors:  Rizwan Ahmad; Bilal Rah; Dhundy Bastola; Punita Dhawan; Amar B Singh
Journal:  Sci Rep       Date:  2017-07-11       Impact factor: 4.379

6.  Methylated claudin-11 associated with metastasis and poor survival of colorectal cancer.

Authors:  Jinyun Li; Chongchang Zhou; Shumin Ni; Shaomin Wang; Chao Ni; Ping Yang; Meng Ye
Journal:  Oncotarget       Date:  2017-10-23

Review 7.  Tight junction proteins in gastrointestinal and liver disease.

Authors:  Mirjam B Zeisel; Punita Dhawan; Thomas F Baumert
Journal:  Gut       Date:  2018-10-08       Impact factor: 31.793

8.  HDAC-4 regulates claudin-2 expression in EGFR-ERK1/2 dependent manner to regulate colonic epithelial cell differentiation.

Authors:  Rizwan Ahmad; Balawant Kumar; Kaichao Pan; Punita Dhawan; Amar B Singh
Journal:  Oncotarget       Date:  2017-09-23

Review 9.  Emerging clinical significance of claudin-7 in colorectal cancer: a review.

Authors:  Kun Wang; Chang Xu; Wenjing Li; Lei Ding
Journal:  Cancer Manag Res       Date:  2018-09-20       Impact factor: 3.989

10.  Functionalization of gold-nanoparticles by the Clostridium perfringens enterotoxin C-terminus for tumor cell ablation using the gold nanoparticle-mediated laser perforation technique.

Authors:  Annegret Becker; Miriam Leskau; Barbara L Schlingmann-Molina; Susanne C Hohmeier; Suhayla Alnajjar; Hugo Murua Escobar; Anaclet Ngezahayo
Journal:  Sci Rep       Date:  2018-10-08       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.